SEARCH

Current Edition

Boehringer

With trial success in kidney disease, Lilly, Boehringer make case for broader use of diabetes drug

Dive Brief: Eli Lilly and Boehringer Ingelheim’s drug Jardiance kept clinical trial participants with kidney disease from needing dialysis or a transplant, the companies announced …

Continue Reading →